Hidetaka Fujii

Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis

Hidetaka Fujii, Yuka Shimada, Minoru Hasegawa et al. · Journal of Dermatological Science · 2004 · 89 citations

Life Sciences, Immunology, Pathobiology +5

Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis.

Shinobu Furuse, Hidetaka Fujii, Yuko Kaburagi et al. · PubMed · 2003 · 76 citations

Medicine, Immunology, Pathology +17

Cycloamylose‐nanogel drug delivery system‐mediated intratumor silencing of the vascular endothelial growth factor regulates neovascularization in tumor microenvironment

Hidetaka Fujii, Masaharu Shin‐Ya, Shigeo Takeda et al. · Cancer Science · 2014 · 63 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

Osteoclast-like giant cell tumour of the gallbladder

M. Ito, Chao‐Tien Hsu, Seiji Naito et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 1992 · 22 citations

Medicine, Oncology, Pathology +12

Drug‐induced hypersensitivity syndrome complicated with concurrent fulminant type 1 diabetes mellitus and Hashimoto’s thyroiditis

Yusuke Minegaki, Yuka Higashida, Makiko Ogawa et al. · International Journal of Dermatology · 2013 · 20 citations

Medicine, Endocrinology, Internal Medicine +15